You are here

  • Home
  • Archive
  • Volume 73, Issue 9
  • Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

Article metrics

Article menu
Download PDFPDF
Original research
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 20209504240
Feb 20206695932
Mar 20204313819
Apr 20204204124
May 20204262723
Jun 20203753123
Jul 20202922613
Aug 20205465336
Sep 20205513428
Oct 20205044722
Nov 20202581914
Dec 20202932328
Jan 20213682813
Feb 20215723227
Mar 20215343824
Apr 20215293120
May 20211322312
Jun 2021664718
Jul 202119217680
Aug 202118915565
Sep 202118816295
Oct 202117615282
Nov 202115212980
Dec 202117515489
Jan 2022188181105
Feb 202221319372
Mar 20223876633
Apr 20224283025
May 20223624011
Jun 20223715428
Jul 202213813366
Aug 202215714669
Sep 202214112480
Oct 202218516756
Nov 202216013579
Dec 202215611964
Jan 2023246147
Feb 2023332248
Mar 2023380285
Apr 2023234192
May 2023323243
Jun 2023230219
Jul 2023184154
Aug 20235952314
Sep 20232181910
Oct 20233493211
Nov 2023267155
Dec 20232771812
Jan 2024189102
Feb 202421755
Mar 20242641910
Total1617932411702